India’s Advinus Therapeutics Launches U.S. Office To Build Clinical Development Knowledge And Client Base
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's biggest pure drug discovery company Advinus Therapeutics, part of the giant steel-to-tea Tata conglomerate, announced it is launching a U.S. operation to build its client base and be closer to cutting-edge medical developments
You may also be interested in...
J&J Teams With Advinus For Drug Discovery In India
NEW DELHI - India's Tata Group company Advinus has formed a drug discovery and early clinical development tie-up with Ortho-McNeil-Janssen Pharmaceuticals, an arm of U.S.-based Johnson & Johnson
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).